Abbott Intrinsic Value
ABBOTINDIA Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹15622.20 | ₹12497.76 - ₹18746.64 | -45.1% | EPS: ₹710.10, Sector P/E: 22x |
| Book Value Method | asset | ₹5688.00 | ₹5119.20 - ₹6256.80 | -80.0% | Book Value/Share: ₹2015.71, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹8532.00 | ₹7678.80 - ₹9385.20 | -70.0% | Revenue/Share: ₹3335.71, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹11376.00 | ₹10238.40 - ₹12513.60 | -60.0% | EBITDA: ₹2103.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹11376.00 | ₹9100.80 - ₹13651.20 | -60.0% | CF Growth: 8.6%, Discount: 15% |
| PEG Ratio Method | growth | ₹9792.88 | ₹8813.59 - ₹10772.17 | -65.6% | EPS Growth: 17.2%, Fair P/E: 13.8x |
| Growth Adjusted P/E | growth | ₹11120.78 | ₹10008.70 - ₹12232.86 | -60.9% | Revenue Growth: 8.8%, Adj P/E: 15.7x |
| ROE Based Valuation | profitability | ₹14220.00 | ₹12798.00 - ₹15642.00 | -50.0% | ROE: 35.6%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹8532.00 | ₹7678.80 - ₹9385.20 | -70.0% | EPS: ₹710.10, BVPS: ₹2015.71 |
Want to compare with current market value? Check ABBOTINDIA share price latest .
Valuation Comparison Chart
ABBOTINDIA Intrinsic Value Analysis
What is the intrinsic value of ABBOTINDIA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Abbott (ABBOTINDIA) is ₹11120.78 (median value). With the current market price of ₹28440.00, this represents a -60.9% variance from our estimated fair value.
The valuation range spans from ₹5688.00 to ₹15622.20, indicating ₹5688.00 - ₹15622.20.
Is ABBOTINDIA undervalued or overvalued?
Based on our multi-method analysis, Abbott (ABBOTINDIA) appears to be trading above calculated value by approximately 60.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 17.12 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.40 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 35.6% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 27.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.18x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Abbott
Additional stock information and data for ABBOTINDIA
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹1,012 Cr | ₹1,012 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹1,213 Cr | ₹1,005 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹893 Cr | ₹819 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹948 Cr | ₹750 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹727 Cr | ₹691 Cr | Positive Free Cash Flow | 8/10 |